Author: Pablo Bolaños
Under the influence: prescription opioids
If someone close to you were struggling with opioid dependence, would you see the signs of addiction? We take a closer look at prescription opioid misuse. Continue reading
The FMCSA’s new database – Clearinghouse coming soon
The FMCSA’s new Clearinghouse database will house commercial motor vehicle drivers’ violations of drug and alcohol programs to help keep roads safer. Continue reading
Hair testing now includes more specific testing for oxycodones
Recent enhancements to our hair testing panels now allow for more specific testing for opiate-like or opioid drug such as oxycodone and its metabolites. Continue reading
I’m there: Anthony Magazzolo
Anthony Magazzolo nurtures strong connections throughout our business to help our extensive, nationwide, drug testing collection network run smoothly. Continue reading
Hair testing webinar in review
In the third and final installment of our webinar series, Back to basics, we focused on hair drug testing and combed through the key features. Continue reading
Ask the experts: Can hair testing detect one-time drug use?
Employers who look for solutions to detect one-time drug use often ask if hair testing may be a viable option. We help to provide insight. Continue reading
Back to basics webinar series: hair drug testing
Untangling the benefits of this drug testing type, Quest experts provide insightful information in our upcoming webinar, Back to basics: hair drug testing. Continue reading
The new age of marijuana
Our new white paper provides insights about the new age of marijuana and the importance of maintaining marijuana testing in a drug-free workplace program. Continue reading
Ask the experts: what is a direct observation drug test collection?
Drug test collections are a critical part of the drug testing process. Ensuring the integrity of specimens collected is equally as important. Continue reading
Preferred collection sites available at Walmart
Effective May 1, 2019, all Walmart PCS locations will be identified as “preferred sites” instead of “Patient Service Centers” in our network Continue reading